Why Eli Lilly (LLY) moves
13 explained moves, each written the day it happened. Trade LLY →
- +1.87%
Raised outlook sends Lilly to a record high
- +6.46%
Raised FY guidance after strong Q3 beat
- +6.36%
Raised FY guidance after strong Q3 beat
- -3.25%
Mixed obesity trial data weighs on pipeline outlook
- +2.78%
Once-weekly insulin FDA nod opens diabetes franchise
- +3.29%
Once-weekly insulin FDA nod opens diabetes franchise
- +2.83%
Foundayo's 30% market share validates weight-loss lead
- +4.60%
Eli Lilly guidance shift sparks 4.9% surge
- +5.19%
Eli Lilly guidance shift sparks 4.9% surge
- +4.22%
Eli Lilly wins U.K. approval for Foundayo weight-loss pill
- +3.91%
UK approval unlocks new obesity market for Lilly
- +3.99%
Eli Lilly beats, raises 2026 outlook on GLP-1 surge
- +4.74%
Eli Lilly beats, raises 2026 outlook on GLP-1 surge